The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

NCT00001070 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-04-14

No results posted yet for this study

Summary

This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.

Conditions

  • HIV Infections

Interventions

DRUG

Oral Vitamin C

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00001070 on ClinicalTrials.gov